Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 4, 2008

View Archived Issues

Amitriptyline beneficial in benign prostatic hyperplasia

AstraZeneca develops 5-HT1B receptor radioligand for PET imaging

Notch inhibition with MRK-003 active in preclinical pancreatic cancer experiments

Recent GSK, Pfizer and Roche patents disclose new antipsychotic agents

Novel therapeutic agents for respiratory and allergic disorders described in recent patents

Recent Bayer and Takeda patents disclose novel compounds for cardiovascular disorders

Snapshots: Recent data on immunoconjugates from ImmunoGen

Interim results from a phase I solid tumor study with weekly EZN-2968

GlaxoSmithKline: Q3 review

FDA accepts IND for ART-621, Arana to commence phase II studies

PAION reports successful meta-analysis for pain drug M6G

Synosia starts phase IIa nepicastat trial in post-traumatic stress disorder

TMC-207 shows promise as a treatment for tuberculosis

FDA approves donated blood screening test for HIV, HCV and HBV

FDA approves Treanda for relapsed indolent non-Hodgkin's lymphoma

Mpex initiates phase II clinical trial of aerosol MP-376 in COPD

Neoprobe receives positive EMEA response to RIGScan CR submission

ProStrakan launches Sancuso in U.S. for chemotherapy-induced nausea

Welichem reports phase IIa results for WBI-1001 atopic dermatitis cream

BioMarin commences clinical assessment program for Morquio A syndrome

MedImmune commences phase I/IIa trial for respiratory syncytial virus vaccine

Portola starts phase II betrixaban trial for stroke prevention in atrial fibrillation

Medarex and MBL report results from phase II trial of MDX-066 and MDX-1388

AEterna Zentaris initiates second stage of patient recruitment in phase II trial of AEZS-108

Canopus reports results from specialized laboratory study of peptide cancer vaccine

Cel-Sci expands licensing agreement for cancer drug Multikine to Orient Europharma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...